These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28552522)

  • 21. Calcium-independent binding of human C-reactive protein to lysophosphatidylcholine in supported planar phospholipid monolayers.
    Goda T; Miyahara Y
    Acta Biomater; 2017 Jan; 48():206-214. PubMed ID: 27815167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfur- and acyl chain-dependent influence of 2-methoxy-lysophosphatidylcholine analogues on β pancreatic cells.
    Drzazga A; Ciesielska A; Gendaszewska-Darmach E
    Curr Top Med Chem; 2015; 15(23):2395-405. PubMed ID: 26088355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.
    Morales P; Whyte LS; Chicharro R; Gómez-Cañas M; Pazos MR; Goya P; Irving AJ; Fernández-Ruiz J; Ross RA; Jagerovic N
    J Med Chem; 2016 Mar; 59(5):1840-53. PubMed ID: 26789378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of lysophosphatidylcholine-induced changes of intracellular calcium in Drosophila S2 cells.
    Wang P; Wang Q; Yang L; Qin QL; Wu YJ
    Life Sci; 2015 Jun; 131():57-62. PubMed ID: 25736969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
    Kabarowski JH; Zhu K; Le LQ; Witte ON; Xu Y
    Science; 2001 Jul; 293(5530):702-5. PubMed ID: 11474113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    Brown AJ; Daniels DA; Kassim M; Brown S; Haslam CP; Terrell VR; Brown J; Nichols PL; Staton PC; Wise A; Dowell SJ
    J Pharmacol Exp Ther; 2011 Apr; 337(1):236-46. PubMed ID: 21233197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119.
    Xu P; Huang S; Guo S; Yun Y; Cheng X; He X; Cai P; Lan Y; Zhou H; Jiang H; Jiang Y; Xie X; Xu HE
    Nat Struct Mol Biol; 2022 Sep; 29(9):863-870. PubMed ID: 35970999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the natural ligand of GPR55?
    Okuno T; Yokomizo T
    J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
    Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
    Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
    Anavi-Goffer S; Irving AJ; Ross RA
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
    Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T
    J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic synthesis of novel phosphoglycolipid analogues as potential agonists of GPR55.
    Abe J; Guy AT; Ding F; Greimel P; Hirabayashi Y; Kamiguchi H; Ito Y
    Org Biomol Chem; 2020 Nov; 18(41):8467-8473. PubMed ID: 33063071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.
    Elbegdorj O; Westkaemper RB; Zhang Y
    J Mol Graph Model; 2013 Feb; 39():50-60. PubMed ID: 23220281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidylcholine induces Ca(2+) mobilization in Jurkat human T lymphocytes and CTLL-2 mouse T lymphocytes by different pathways.
    Wang Q; Wu YJ
    Eur J Pharm Sci; 2011 Dec; 44(5):602-9. PubMed ID: 22019492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is GPR55 an anandamide receptor?
    Brown AJ; Robin Hiley C
    Vitam Horm; 2009; 81():111-37. PubMed ID: 19647110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
    Hofmann NA; Yang J; Trauger SA; Nakayama H; Huang L; Strunk D; Moses MA; Klagsbrun M; Bischoff J; Graier WF
    Br J Pharmacol; 2015 Aug; 172(16):4107-18. PubMed ID: 25989290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.
    Wolfram Kuhlmann CR; Wiebke Lüdders D; Schaefer CA; Kerstin Most A; Backenköhler U; Neumann T; Tillmanns H; Erdogan A
    J Mol Cell Cardiol; 2004 May; 36(5):675-82. PubMed ID: 15135662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.